Med Tech Market
James discusses the impact of GLP one drugs on med tech companies, highlighting Resmed's struggles and Weight Watchers' pivot. Joe emphasizes the challenges of competing with giants like Eli Lilly in the GLP one space, cautioning against following secondary plays in the market.In this clip
From this podcast
Odd Lots
Lots More on What's Hot at JPM's Health Conference
Related Questions